Affymax, Inc. Share Price Nasdaq
Equities
US00826A1097
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
Sales 2012 | 94.37M 7.83B | Sales 2013 | 1.37M 114M | Capitalization | 29.24M 2.43B |
---|---|---|---|---|---|
Net income 2012 | -93M -7.72B | Net income 2013 | -14M -1.16B | EV / Sales 2012 | 6.75 x |
Net cash position 2012 | 69.14M 5.74B | Net cash position 2013 | 5.6M 465M | EV / Sales 2013 | 17.3 x |
P/E ratio 2012 |
-7.39
x | P/E ratio 2013 |
-2.03
x | Employees | - |
Yield 2012 * |
-
| Yield 2013 |
-
| Free-Float | 100% |
1st Jan change | Capi. | |
---|---|---|
+67.53% | 63.85B | |
-0.77% | 41.83B | |
+45.66% | 40.65B | |
-10.72% | 27.12B | |
+13.30% | 26.52B | |
-22.79% | 18.69B | |
+4.70% | 12.73B | |
+24.10% | 12.11B | |
+27.41% | 12.07B |